IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9527885 B1

PDFFull Text
Date of Patent:
Dec. 27, 2016

Filed:

Jan. 08, 2015

Hepatitis c virus inhibitors

Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Sheldon Hiebert, Steinbach, CA;

Ramkumar Rajamani, Woodbridge, CT (US);

Li-Qiang Sun, Glastonbury, CT (US);

Eric Mull, Guilford, CT (US);

Eric P. Gillis, Cheshire, CT (US);

Michael S. Bowsher, Prospect, CT (US);

Qian Zhao, Wallingford, CT (US);

Nicholas A. Meanwell, East Hampton, CT (US);

Kishore V. Renduchintala, Bangalore, IN;

Kandhasamy Sarkunam, Hosur, IN;

Pulicharla Nagalakshmi, Bangalore, IN;

P.V.K. Suresh Babu, Bangalore, IN;

Paul Michael Scola, Glastonbury, CT (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:

Pamela A. Mingo

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Stephanie Springer

Int. Cl.
CPC ...
C07D 225/02 (2006.01); C07K 5/097 (2006.01); C07D 487/04 (2006.01); C07K 5/083 (2006.01); C07K 5/08 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61K 31/13 (2006.01); A61K 31/4745 (2006.01); A61K 31/7056 (2006.01); A61K 38/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 5/0823 (2013.01); A61K 31/13 (2013.01); A61K 31/4745 (2013.01); A61K 31/7056 (2013.01); A61K 38/06 (2013.01); A61K 38/204 (2013.01); A61K 38/2013 (2013.01); A61K 38/2053 (2013.01); A61K 38/21 (2013.01); A61K 38/212 (2013.01); A61K 45/06 (2013.01); C07D 487/04 (2013.01); C07K 5/0804 (2013.01); C07K 5/0827 (2013.01); A61K 38/00 (2013.01);
Abstract

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Find Patent Forward Citations

Loading…